Stride Pharma is an oversold zone and indicators are hinting at a change in direction. Stride Pharma is involved in the production of Sputnik Vaccine. Recently acquired a manufacturing plant in New York which implies that the company is in a phase of global expansion. In my opinion we can expect a target of 806.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.